Hold control (command on a Mac) and press the + key as many times as necessary to increase the font size.
Hold control (command on a Mac) and press the - key to reduce the font size. - hide
Online Bulletin Board Support Group Users: click "Forum" to view archives and post messages. - hide
Show/Hide

Shop 'Til You Drop - And Help the GDATF!

Nov. 13, 2017

Did you know that your regular online shopping can help the GDATF fund its patient education and support programs?  By purchasing through one of the following channels, online retailers will donate a portion of proceeds to the Graves’ Disease & Thyroid Foundation - at no cost to you!

Amazon Smile Program
iGive
eBay

Amazon Smile Program: Use your regular Amazon login from the Amazon Smile link, and 0.5% of your total purchase will be donated to ...

Read More

  • Shop 'Til You Drop - And Help the GDATF!

    Nov. 13, 2017

    Did you know that your regular online shopping can help the GDATF fund its patient education and support programs?  By purchasing through one of the following channels, online retailers will donate a portion of proceeds to the Graves’ Disease & Thyroid Foundation - at no cost to you!

    Amazon Smile Program
    iGive
    eBay

    Amazon Smile Program: Use your regular Amazon login from the Amazon Smile link, and 0.5% of your total purchase will be donated to ...

    Read More

  • Thyroid Eye Disease Breakthrough!

    June 30, 2017

    If you've been diagnosed with thyroid eye disease, you know that the current options leave much to be desired: wait, wait, wait, wait some more -- and eventually get approved for one or more surgeries to address bulging, swelling, and double vision. (With steroid therapy sometimes used as a temporary stopgap).  However, the successful trial of a brand new drug could prove to be a game-changer for patients living with this disfiguring and frustrating condition ...

    Read More

  • Wilmer Eye Institute Thyroid Eye Disease Study

    June 30, 2017

    The Johns Hopkins Wilmer Eye Institute is currently recruiting patients for a new clinical study using celecoxib (Celebrex), a non-steroidal anti-inflammatory drug approved by the Food and Drug Administration (FDA) for the treatment of pain, osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as a treatment for active thyroid eye disease (TED).  The study is intended to evaluate the efficacy of COX-2 inhibition in the treatment of active TED and its ability to improve both the acute ...

    Read More

  • Recent Forum Posts

Questions? Problems? Please contact us at [email protected] or 877-643-3123.

GDATF on Facebook
Thank you to our Diamond Sponsors:
Quidel-Thyretain The Bell Charitable Foundation

Support the GDATF and become a member today!

© 2017 Graves' Disease & Thyroid Foundation